Literature DB >> 31692031

Molecular chaperone HspB2 inhibited pancreatic cancer cell proliferation via activating p53 downstream gene RPRM, BAI1, and TSAP6.

Ze Yu1, Hao Wang1, Yilin Fang1, Liangliang Lu1, Minghao Li1, Bingru Yan1, Yuzhe Nie1, Chunbo Teng1.   

Abstract

Heat shock proteins (HSPs) were known as the molecular chaperones, which play a pivotal role in the protein quality control system, ensuring correct folding of proteins, and facilitating the correct refolding of damaged proteins via the transient interaction with their substrate proteins. They also practice in the regulation of cell cycles and are involved in apoptosis. We found that HspB2 was almost completely silent in pancreatic cancer and few studies investigated the role of HspB2 in cancer cells, particularly in pancreatic cancer. Here, we reported that HspB2 effectively inhibited cell proliferation in Panc-1 cells. Specifically, we demonstrated that HspB2 could combine mut-p53 and change the DNA binding site of mutant p53, subsequently upregulated the expression of RPRM, BAI-1, and TSAP6 which were the downstream genes of wt-p53, participate in mediating downstream responses to p53, including inhibiting cell proliferation and angiogenesis. The main aim of this study is to investigate the relationship between HspB2 and p53, and provide a novel treatment strategy for pancreatic cancer.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  BAI-1; HspB2; Panc-1mm; RPRM; TSAP6; p53

Mesh:

Substances:

Year:  2019        PMID: 31692031     DOI: 10.1002/jcb.29455

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  8 in total

1.  miR-17-5p promotes the invasion and migration of colorectal cancer by regulating HSPB2.

Authors:  Weifang Yu; Jia Wang; Chao Li; Mingda Xuan; Shuangshuang Han; Yingfu Zhang; Pengfei Liu; Zengren Zhao
Journal:  J Cancer       Date:  2022-01-01       Impact factor: 4.207

2.  Machine learning-based screening of the diagnostic genes and their relationship with immune-cell infiltration in patients with lung adenocarcinoma.

Authors:  Shuying Wang; Qiong Wang; Bin Fan; Jiao Gong; Liping Sun; Bo Hu; Deqing Wang
Journal:  J Thorac Dis       Date:  2022-03       Impact factor: 2.895

3.  High mRNA Expression Levels of Heat Shock Protein Family B Member 2 (HSPB2) Are Associated with Breast Cancer Patients' Relapse and Poor Survival.

Authors:  Aimilia D Sklirou; Despoina D Gianniou; Paraskevi Karousi; Christina Cheimonidi; Georgia Papachristopoulou; Christos K Kontos; Andreas Scorilas; Ioannis P Trougakos
Journal:  Int J Mol Sci       Date:  2022-08-28       Impact factor: 6.208

4.  Matrix stiffness-dependent STEAP3 coordinated with PD-L2 identify tumor responding to sorafenib treatment in hepatocellular carcinoma.

Authors:  Shunxi Wang; Long Chen; Wanqian Liu
Journal:  Cancer Cell Int       Date:  2022-10-13       Impact factor: 6.429

5.  Ferroptosis in glioma treatment: Current situation, prospects and drug applications.

Authors:  Yuhang Zhou; Chaoyou Fang; Houshi Xu; Ling Yuan; Yibo Liu; Xiaoyu Wang; Anke Zhang; Anwen Shao; Danyang Zhou
Journal:  Front Oncol       Date:  2022-09-29       Impact factor: 5.738

6.  A Novel Immune-Related Seventeen-Gene Signature for Predicting Early Stage Lung Squamous Cell Carcinoma Prognosis.

Authors:  Tao Fan; Zhiliang Lu; Yu Liu; Liyu Wang; He Tian; Yujia Zheng; Bo Zheng; Liyan Xue; Fengwei Tan; Qi Xue; Shugeng Gao; Chunxiang Li; Jie He
Journal:  Front Immunol       Date:  2021-06-11       Impact factor: 7.561

7.  The Tumor Suppressive Roles and Prognostic Values of STEAP Family Members in Breast Cancer.

Authors:  Hua-Tao Wu; Wen-Jia Chen; Ya Xu; Jia-Xin Shen; Wen-Tian Chen; Jing Liu
Journal:  Biomed Res Int       Date:  2020-08-03       Impact factor: 3.411

8.  Identification of a Seven-lncRNA-mRNA Signature for Recurrence and Prognostic Prediction in Relapsed Acute Lymphoblastic Leukemia Based on WGCNA and LASSO Analyses.

Authors:  Haiyan Qi; Long Chi; Xiaogang Wang; Xing Jin; Wensong Wang; Jianping Lan
Journal:  Anal Cell Pathol (Amst)       Date:  2021-06-09       Impact factor: 2.916

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.